Skip to content

重要的地貧科研項目 Project List

1. Iron chelation

  • Purchase of Ambulatory infusion pump for intensified iron chelation
  • Oral Chelation Project by University of Hong Kong
  • Oral Chelator Project
  • Comparison of Subcutaneous Infusion Sets for Thalassaemia Patients
  • Follow-on project on the use of L1, the oral chelator
  • Effect of Different Clinically Used Chelators (DFO & L1) on the Growth of Bacteria Commonly Found in Local Thalassaemia Major Patients
  • The Use of Deferasirox (Exjade) by Protocol-driven Iron Chelation which Targets at Near-Normal Body Iron Status in terms of Serum Ferritin and MRI T2* Measurements
  • Use of low dose deferasirox in transfusion-dependent thalassaemia patients after hematopoietic stem cell transplantation
  • Iron chelation therapy in non-transfusioin dependent thalassaemia patients
Iron chelation

2. Assessment of iron overload

  • MR screening for iron overload in Thalassaemia patients
  • Imaging iron stores in the brain using susceptibility-weighted MR imaging (SWI) in patients with β-thalassaemia major (TM) and correlation with cognitive function.
  • MRI study for iron overload in thalassaemia intermedia patients and thalassaemia major patients after hematopoietic stem cell transplantation
  • Thalassaemia major: a new MRI method for monitoring heart and liver iron deposition
  • Circulating Microparticles as Surrogate Markers of Iron Induced Organ Damage in Beta-Thalassaemic Patients
  • Ex vivo study of dendritic cell functions under iron overload conditions in thalassaemia patients
  • Longitudinal study on iron overload status after introduction of MRI T2* Measurement on Heart and Liver Iron for Thalassaemia Major Patients in Hong Kong
  • Novel MRI T1 mapping for estimation of T1 relaxation time of myocardium in patients with beta-thalassaemia major
Assessment of iron overload

3. Cardiac function

  • New echocardiographic indices for early detection of abnormal heart functions in Thalassaemia patients
  • Study on use of oral chelator in reversing poor cardiac function and vascular stiffness of transfusion – dependent thalassaemic patients
  • Tissue Doppler echocardiography in patients with Thalasseamia for early myocardial dysfunction
  • Circulating Endothelial and Endothelial Progenitor Cells, Arterial Function, and Ventriculo-Arterial Interaction in Patients with Beta-Thalassaemia Major
  • Novel Real-Time 3-Dimensional Echocardiographic Assessment of Right and Left Ventricular Function in Patients with Beta-Thalasaemia Major
  • Ventricular Mechanical Dyssynchrony in Iron Loaded Patients with Beta-Thalassaemia Major
  • Induction of Endothelial Microparticle Generation by Plasma of Beta-Thalassaemia
    Major Patients: Effect of Different Chelating Regiments and Role of Carvedilol
  • Myocardial Fibrosis of the Right and Left Ventricles in Thalassaemia Major
  • The Role of New Three Dimensional Wall Motion Tracking Echocardiography in the Quantification of Global Myocardial Mechanics and Iron Load in Patients with Beta-Thalassaemia Major
  • Right and Left Atrial Function in Patients with Thalassaemia Major: Interaction with Ventricular Diastolic Function and Arterial Mechanics
Cardiac function
Cardiac function

4. Osteoporosis

  • Cross-sectional survey of incidence of osteoporosis and osteopenia among patients with thalassaemia major, thalassaemia intermedia and haemoglobin H disease, and one-year prospective trial of oral bisphosphonate treatment for osteoporosis in thalassaemia patients
  • A one-year placebo double blinded trial on additional benefit of aledronate in the treatment of osteoporosis and osteopenia among patients with Thalassaemia major, thalassaemia intermedia and hemoglobin H disease in thalassaemia patients
  • Pilot Study of denosumab in thalassaemia major patients with osteoporosis

5. Immune function

  • Dysregulation of Immune Function in Thalassaemia Patient and Implications for Clinical Care
  • Effects of Iron Overload on Immune Cells Differentiation and Function: Impact on Thalassaemia Patients’ Body Defense Status
  • Cytokine profile predicting immune dysfunction in iron overloaded thalassaemia patients
  • The role of iron overload on innate response against Klebsiella infection
  • Evaluation of Thymic Output and T-cell Senescence in Patients with Transfusion-Dependent and Non-Transfusion Dependent Thalassaemia

6. Genetics and laboratory diagnosis

  • Project of Genetic Modifiers of Beta-Thalassemia Phenotype
  • Iron overload in Thalassaemia: the role of genetic factors
  • Iron Absorption & Genetic Factors in Patients with Hb H Disease
  • Detection of genetic mutations in beta-globin gene cluster using a new molecular technique
  • Investigation of genetic determinants controlling fetal haemoglobin levels in Chinese individuals with β-thalassaemia and hereditary persistence of fetal haemoglobin
  • Molecular characterization of β-globin gene cluster alterations in Chinese hereditary persistence of fetal haemoglobin (HPFH) and β-thalassaemia subjects with elevated fetal haemoglobin
  • A Molecular Screening Study to document the Prevalence and Genotype of Globin Gene Disorders in Hong Kong
  • A Molecular Study on the Role of Alpha-Haemoglobin Stabilising Protein in modulating disease severity of Haemoglobin H disease.
  • A pilot study on the genetic screening in thalassaemia trait carrier couples
  • HBD mutation: molecular characterization, prevalence and implications for antenatal screening program in local Chinese
  • Development of a genetic testing method by next generation sequencing for Thalassaemia—a pilot study
Genetics and laboratory diagnosis
Genetics and laboratory diagnosis

7. Prevention

  • Preimplantation Diagnosis (PGD) of Thalassaemia
  • Examination of maternal plasma DNA for prenatal exclusion of beta-thalassaemia major
  • Detection of non-deletional mutations of β-globin gene cluster in patients with unexplained βthalassaemia and hereditary persistence of fetal haemoglobin
  • Preimplantation genetic diagnosis of beta thalassaemia and HLA typing using the whole genome amplification method.
  • Preimplantation genetic diagnosis of alpha thalassaemia and aneuploidy screening using next generation sequencing technology
  • Development of a one-stop thalassaemia screening method by next generation sequencing

8. Obstetrics

  • A study on the Prevention of Gestational Diabetes Mellitus in Women with Alpha & Beta Thalassaemia Traits in Hong Kong
  • Fertility assessment of patients with major beta thalassaemia
  • A randomized controlled trial to study the effect of folic acid supplementation in pregnant women having thalassaemia trait

9. Haemopoietic stem cell transplantation

  • Quality of Life assessment for patients with transfusion-dependent thalassaemia after hemopoietic stem cell transplantation
  • Haemopoietic stem cell transplantation for patients with thalassaemia major using HLA matched unrelated donor bone marrow or unrelated cord blood
  • Evaluation of gonadal dysfunction after hematopoietic stem cell transplantation in patients with transfusion dependent thalassaemia
  • Retrospective analysis of patient / donor pairs by high resolution HLA (Human Leucocyte Antigen) typing for the cohort of patients with thalassaemia major TM who had undergone donor haemopoietic stem cell transplantation
  • Allogeneic unrelated hematopoietic stem cell transplantation for patients with transfusion-dependent thalassaemia
  • A Preclinical Investigation on Promotion of Cord Blood Hematopoietic Stem Cell Homing and Engraftment by Downregulating RGS1, RGS13 and RGS16 Gene Expression
  • In-utero stem cell transplant for fetal haemoglobin Bart’s disease (Hb Bart’s disease)

10. New treatment

  • L-carnitine for treatment of patients with beta-thalassaemia intermedia
  • Protective effect of thrombopoietin on iron-induced cardiomyopathy
  • Prevention of Cellular Iron Overload by Calcium Channel Blockers
  • The protective effects of thrombopoietin and amlodipine on iron overload-induced human mesenchymal stem cell damage: its impact on iron overload related osteopenia & osteoporosis.
  • Pilot Study of Efficacy and safety of Chinese Herbal medicine Gualou (fructus trichosanthis) in Treating beta-thalassaemia Intermedia Patients.
  • Prevention of cellular iron overload by calcium channel blockers: Assessing the intracelluar labile iron accumulation with or without the use of calcium channel blockers
  • Effect of Bismuth compound as anti-oxidant for iron overload protection

11. Other complications

  • Daytime sleepiness and obstructive sleep apnoea in children and adolescents with beta-thalassaemia – a pilot study
  • Pulmonary function in β-thalassaemia major: follow-up and airway inflammation study
  • Renal dysfunction in patients with transfusion-dependent thalassaemia (REDEFINE study)

12. Gene therapy and editing

  • Using gene editing tool (CRISP/Cas9) to improve hemoglobin production by erythropoietic cells derived from β-thalassaemia patient-specific iPSCs
  • Gene therapies targeting BCL11A for beta-thalassemia treatment development
  • Development of Gene Therapy for β-Thalassaemias through Therapeutic Genome Editing in Human Blood Stem Cells
Prevention